Clinical Trial Update: The Organ Protection of Astragalus in Subjects With Metabolic Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the organ-protective effects of Astragalus in subjects with Metabolic Syndrome has completed. The document is a status update …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Astragalus (Astragalus membranaceus)

Snippet

Sponsor: LanZhou University | Conditions: Metabolic Syndrome | Phase 3 | Status: COMPLETED